ArticlePeerJ2023

Plasma thrombin-activatable fibrinolysis inhibitor and the 1040C/T polymorphism are risk factors for diabetic kidney disease in Chinese patients with type 2 diabetes.

Qinghua Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.